Compliance, Risk and Cost of Ownership Comparisons for Pharmaceutical Continuous Monitoring

Quality manager in pharmaceutical-related industries can now obtain a guide to cutting costs of monitoring critical environments while controlling risk factors from Veriteq, a Vaisala company.  Copies of this no-cost white paper “ Compliance, Risk and Cost of Ownership Comparisons for Pharmaceutical Continuous Monitoring-Wired, Wireless and Standalone Monitoring Instruments”.

Six different modalities used in pharmaceutical-related industries for continuous monitoring-chart recorders, standalone data loggers, wired LAN networks with UPS backups, wired LAN networks using Power over Ethernet; WiFi; and Wireless Mesh-are systematically explained and compared in terms of lifetime costs of ownership and risks of non-compliance in the context of today’s regulatory environment.

Ken Appel, Manager of Regulated Industries for Veriteq, a Vaisala company, and author of the white paper explains that he wrote it to address the commonly overlooked sources of human error inherent in various monitoring modalities and to provide a systematic way for quality managers to weigh the pros and cons of different approaches to continuous monitoring.  Mr. Appel says, “Whether you choose one connectivity method over the other or a combination, you will have to decide what makes the most sense in your organization.  There is no one solution that fits every situation.  Always though, a concern is to address the level of risk you can afford, and to know what these risks are.   Understandably, these decisions do not occur in a vacuum. Physical plant layout, existing IT infrastructure, support resources and management buy-in to name a few, will likely influence your path.”    

Quelle: Veriteq, a Vaisala company

Ähnliche Beiträge

Schreibe einen Kommentar